৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
Therapeutic Class: Oral Iron preparations
Control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.
Treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.
Ferric iron binds dietary phosphate in the GI tract and precipitates as ferric phosphate, which is insoluble and excreted in stool. This reduces phosphate absorption and lowers serum phosphate concentration. Ferric iron is reduced to ferrous form by ferric reductase, absorbed via enterocytes, and circulates bound to transferrin for incorporation into hemoglobin.
Hyperphosphatemia (CKD on dialysis): Start with 2 tablets orally, 3 times daily with meals. Adjust as needed, up to 12 tablets/day.
Iron Deficiency Anemia (CKD not on dialysis): Start with 1 tablet orally, 3 times daily with meals. Adjust as needed, up to 12 tablets/day.
Children & Adolescents: Safety and efficacy not established.
Separate administration from oral drugs such as Doxycycline & Ciprofloxacin.
Contraindicated in patients with iron overload syndrome (Hemochromatosis).
Discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, hyperkalemia.
No available data in pregnant or lactating women.
May cause excessive elevations in iron stores (↑ serum ferritin, ↑ TSAT).
Risk of accidental overdose in children under 6 years — keep out of reach.
No data available. Maximum studied dose in CKD patients: 2,520 mg ferric iron/day.





N/A
N/A



